2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer
B

Basic Mechanisms of Action in Immuno-Oncology: Understanding the Immune System and Immunotherapy in Cancer Treatment

By 2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer FEATURING Bernardo Rapoport
By 2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer FEATURING Bernardo Rapoport
56 views
September 10, 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
29:43
Michigan Medicine

GI and Hepatic Complications of Cancer Immunotherapy

Feat. R. Fontana
11:43
University of Colorado Department of Medicine

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

Feat. L. Kondapalli
18:46
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson
38:47
Medical College of Georgia - Augusta University

Oncologic Emergencies: The Clock Is Ticking

Feat. G. Raval
21:45
International Congress on Cancer Metastasis

Immunotherapy and Targeted Therapy for Personalized Cancer Treatment

Feat. K. Kim
25:03
Total Health

Hungry for Data: The Connection Between Diet and Cancer and Selected…

Feat. T. Berman
14:29
Total Health

Updates on Universal Comprehensive Genomic Profiling & Treatment…

Feat. R. Salgia
30:53
Beth Israel Deaconess Medical Center

The Role of the Intestinal Microbiome in Cancer Immunotherapy

Feat. M. Van Den Brink
21:48
Houston Methodist Hospital

Tumor-Infiltrating Lymphocytes for Clinicians

Feat. S. Ganguly
34:35
Beth Israel Deaconess Medical Center

Updates in T-Cell Immunotherapies

Feat. C. Wu
16:27
Insights from 2023 SITC Annual Meeting

SITC 2023 Insights: "AI-Designed Personalized Neoantigen Vaccin…

Feat. D. Kleine-Kohlbrecher
21:43
Yale Cancer Center

The Role of Surgery After Neoadjuvant Systemic Therapy for Cancer

Feat. C. Balch
44:24
McMaster University Department of Medicine

Immune Checkpoint Inhibitor Toxicities in the ICU: A Review

Feat. A. Zereshkian, R. Gerber, L. Spatafora
06:04
Insights from ELCC 2024

ELCC 2024 Insights: "Can We Modulate Lung Cancer IO Response Wi…

Feat. P. Baas
48:25
Dana-Farber Cancer Institute

Behind the Breakthroughs: Activating the Immune System to Prevent Ca…

Feat. I. Ghobrial, S. Syngal, M. Yurgelun, B. Ebert
19:36
EADV 2022 Conference Coverage

EADV 2022: Microbiota and Biofilms in Hidradenitis Suppurativa

Feat. A. Nassif
17:53
Oncology Data Advisor

The Rise of Cancer Immunotherapy: Considerations for Optimal Managem…

Feat. M. Hadfield
48:29
Yale Cancer Center

Therapeutic Targeting of Epigenetic Mechanisms in Cancer

Feat. S. Armstrong
47:26
Moffitt Cancer Center

Basic and Translational Immunotherapy Approaches in Head and Neck Ca…

Feat. R. Uppaluri
45:00
Nebraska Oncology Society

Tissue-Based Predictors of Immunotherapy

Feat. N. Vokes